ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+2.18%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$339M
AUM Growth
+$339M
(+12%)
Cap. Flow
+$29.1M
Cap. Flow
% of AUM
8.58%
Top 10 Holdings %
Top 10 Hldgs %
40.44%
Holding
118
New
22
Increased
42
Reduced
29
Closed
25
Top Buys
| 1 |
Merck
MRK
|
$9.08M |
| 2 |
Labcorp
LH
|
$7.04M |
| 3 |
Universal Health Services
UHS
|
$6.49M |
| 4 |
Johnson & Johnson
JNJ
|
$6.32M |
| 5 |
Becton Dickinson
BDX
|
$5.84M |
Top Sells
| 1 |
AMSG
Amsurg Corp
AMSG
|
$6.25M |
| 2 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$5.94M |
| 3 |
Hologic
HOLX
|
$5.76M |
| 4 |
Teleflex
TFX
|
$4.42M |
| 5 |
Community Health Systems
CYH
|
$4.33M |
Sector Composition
| 1 | Healthcare | 89.84% |
| 2 | Financials | 0.85% |
| 3 | Technology | 0.78% |
| 4 | Real Estate | 0.25% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Danaher
DHR
$143B
| $1.76M | 0.52% |
30,575
-30,501
| -50% | -$1.75M |
|
|
52
Teleflex
TFX
$5.57B
| $1.61M | 0.48% |
11,900
-32,600
| -73% | -$4.42M |
|
53
Edwards Lifesciences
EW
$47.7B
| $1.58M | 0.47% |
+66,600
| New | +$1.58M |
|
54
DaVita
DVA
$9.72B
| $1.45M | 0.43% |
18,200
+15,553
| +588% | +$1.24M |
|
55
Amgen
AMGN
$153B
| $1.41M | 0.42% |
9,200
+7,100
| +338% | +$1.09M |
|
|
AMSG
56
DELISTED
Amsurg Corp
AMSG
| $1.38M | 0.41% |
19,759
-89,341
| -82% | -$6.25M |
|
57
Illumina
ILMN
$15.2B
| $1.36M | 0.4% |
6,419
-411
| -6% | -$87.3K |
|
58
Cencora
COR
$57.2B
| $1.34M | 0.4% |
12,604
+2,504
| +25% | +$266K |
|
|
NXTM
59
DELISTED
NxStage Medical Inc.
NXTM
| $1.25M | 0.37% |
87,293
+20,200
| +30% | +$289K |
|
60
CVS Health
CVS
$93B
| $1.23M | 0.36% |
+11,700
| New | +$1.23M |
|
61
PTC Therapeutics
PTCT
$4.41B
| $1.16M | 0.34% |
+24,100
| New | +$1.16M |
|
62
Abbott
ABT
$230B
| $1.1M | 0.32% |
22,350
+1,700
| +8% | +$83.4K |
|
|
AFFX
63
DELISTED
AFFYMETRIX INC
AFFX
| $1.06M | 0.31% |
+96,700
| New | +$1.06M |
|
|
RAD
64
DELISTED
Rite Aid Corporation
RAD
| $983K | 0.29% |
5,885
+600
| +11% | +$100K |
|
65
Standard BioTools
LAB
$493M
| $924K | 0.27% |
+38,200
| New | +$924K |
|
|
MDVN
66
DELISTED
MEDIVATION, INC.
MDVN
| $881K | 0.26% |
15,434
-25,866
| -63% | -$1.48M |
|
|
OCRX
67
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $878K | 0.26% |
231,141
+71,939
| +45% | +$273K |
|
|
VIRX
68
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $868K | 0.26% |
1,373
+706
| +106% | +$446K |
|
|
UHT
69
Universal Health Realty Income Trust
UHT
$562M
| $850K | 0.25% |
+18,300
| New | +$850K |
|
|
NVRO
70
DELISTED
NEVRO CORP.
NVRO
| $779K | 0.23% |
+14,500
| New | +$779K |
|
|
SSRG
71
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $761K | 0.22% |
87,249
-48,803
| -36% | -$426K |
|
|
GHDX
72
DELISTED
Genomic Health, Inc.
GHDX
| $756K | 0.22% |
+27,200
| New | +$756K |
|
|
MNK
73
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $743K | 0.22% |
6,309
-17,300
| -73% | -$2.04M |
|
|
ANAC
74
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $720K | 0.21% |
9,300
-4,900
| -35% | -$379K |
|
75
Neurocrine Biosciences
NBIX
$13.5B
| $712K | 0.21% |
+14,900
| New | +$712K |
|